Persistent keratoacantoma: Challenges in management

Dermatologic Surgery

Volumn 24, Issue 12, 1998, Pages 1364-1369

  Canas, G C ^a   Robson, K J ^a   Arpey, C J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; INTERFERON; ISOTRETINOIN; METHOTREXATE; RETINOID;

ADULT; ARTICLE; CASE REPORT; HISTOPATHOLOGY; HUMAN; KERATOACANTHOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REMISSION; SKIN SURGERY; TREATMENT OUTCOME; TUMOR DIAGNOSIS; ADJUVANT CHEMOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; PATHOLOGY; SKIN; SKIN TUMOR; TUMOR RECURRENCE;

ADMINISTRATION, ORAL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; ISOTRETINOIN; KERATOACANTHOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0032217273     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb00016.x     Document Type: Article

References (24)

1. Bergman BA, Brown RE. Blastomycosis infection of the hand. Ann Plast Surg 1994 ; 33: 330–2.
2. Dismukes WE, Bradsher RW, Cloud GC, et al Itraconazole therapy for blastomycosis and histoplasmosis. Am J Med 1992 ; 93: 489–97.
3. Zuckerman JM, Tunkel AR. Itraconazole: a new triazole antifungal agent. Infect Control Hosp Epidemiol 1994 ; 15: 397–410.
4. Al‐Mishari MA. Clinical and bacteriological evaluation of tetracycline and erythromycin in acne vulgaris. Clin Ther 1987 ; 9: 273–80.
5. Jeffes EW, Ahmed AR. Adjuvant therapy of bullous pemphigoid with dapsone. Clin Exp Dermatol 1989 ; 14: 132–6.
6. Elder D, Elenitsas R, Jaworsky C, et al. eds. Lever's Histopathology of the Skin. 8th Ed. Philadelphia: Lippincott‐Raven, 1997 ; 731–4.
7. Patel A, Halliday GM, Cooke BE, et al. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994 ; 131: 789–98.
8. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994 ; 30: 1–19.
9. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992 ; 27: 241–8.
10. Flowers F, Ramos‐Caro FA. Solitary keratoacanthoma (squamous cell carcinoma): surgical management. Int J Dermatol 1995 ; 34: 17–9.
11. Larson PO. Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery). J Am Acad Dermatol 1987 ; 16: 1040–4.
12. Melton JL, Nelson BR. Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 1991 ; 25: 1017–23.
13. Hurst LN, Gan BS. Intralesional methotrexate in keratoacanthoma of the nose. Br J Plast Surg 1995 ; 48: 243–6.
14. Parker CM, Hanke CW. Large keratoacanthomas in difficult locations treated with intralesional 5‐fluorouracil. J Am Acad Dermatol 1986 ; 14: 770–7.
15. Sayama S, Tagami H. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol 1983 ; 109: 449–52.
16. Wong WYL, Kolbusz RV. Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int J Dermatol 1994 ; 33: 579–83.
17. Street ML, White JW. Multiple keratoacanthomas treated with oral retinoids. J Am Acad Dermatol 1990 ; 23: 862–6.
18. Schaller M, Korting HC. Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: development in a single patient and treatment with oral isotretinoin. Acta Derm Venereol (Stockh) 1996 ; 76: 40–2.
19. Benoldi D, Alinova A. Multiple persistent keratoacanthomas: treatment with oral etretinate. J Am Acad Dermatol 1984 ; 10: 1035–8.
20. Cristofolini M, Piscioli F, Zumiani G, et al. The role of etretinate (Tegison, Tigason) in the management of keratoacanthoma. J Am Acad Dermatol 1985 ; 12: 633–8.
21. Goldberg LH, Rosen T, Becker J, et al. Treatment of solitary keratoacanthomas with oral isotretinoin. J Am Acad Dermatol 1990 ; 23: 934–6.
22. Grob JJ, Suzini F, Weiller RM, et al. Large keratoacanthomas treated with intralesional interferon alfa‐2a. J Am Acad Dermatol 1993 ; 29: 237–41.
23. Goldschmidt H, Sherwin WK. Radiation therapy of giant aggressive keratoacanthomas. Arch Dermatol 1993 ; 129: 1162–5.
24. Shaw JC, Storrs FJ, Everts E. Multiple keratoacanthomas after megavoltage radiation therapy. J Am Acad Dermatol 1990 ; 23: 1009–11.